ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
6,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
9,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
11,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
12,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
13,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
14,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
14,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
15,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
16,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
17,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
19,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
20,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
20,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
20,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
21,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
22,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
23,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
23,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
23,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
24,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
26,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
26,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
27,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
28,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
28,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
29,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
29,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
29,5,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,6,Urine analysis,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
30,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
31,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
31,2,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
31,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
32,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
33,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
33,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
33,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
34,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
34,2,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
35,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
36,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
37,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
38,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
38,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
38,4,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
38,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
39,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
39,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,1,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
40,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
41,1,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
41,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
42,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
43,1,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
43,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
43,3,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
44,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
44,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
44,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
45,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
45,2,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
45,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
46,1,Blood osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
46,2,Glucose tolerance decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
47,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
47,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
48,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
49,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
50,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,4,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
50,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
51,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
51,3,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
53,2,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
53,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
53,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
55,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
56,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
57,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
58,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
59,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
60,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
61,3,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
62,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
63,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
64,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
64,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
64,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
64,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
64,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
64,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
64,7,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
64,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
65,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
65,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
67,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
67,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
67,6,Headache,Headaches NEC,Headaches,Nerv,N
67,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
67,8,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
67,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
67,10,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
67,11,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
67,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,13,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
67,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
68,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
68,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
69,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
69,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
69,3,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
70,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
73,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
73,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
73,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
73,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
73,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
73,6,Headache,Headaches NEC,Headaches,Nerv,N
73,7,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
73,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
74,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
75,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
76,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
76,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
77,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
78,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
79,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
80,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
82,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
82,2,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
83,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
83,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
83,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
84,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
84,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
84,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
85,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
85,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
86,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
86,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
87,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
87,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
87,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
88,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
89,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
90,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
91,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
91,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
91,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
91,5,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
92,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
92,3,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
92,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
92,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
93,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
94,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
94,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
95,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
96,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
96,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
97,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
98,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
98,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
99,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
101,1,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
102,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
103,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
103,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
103,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
104,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
104,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
104,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
105,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
105,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
105,4,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
105,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
106,1,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
106,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
106,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
107,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
108,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
110,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
111,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
111,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
111,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
112,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
113,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
113,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
113,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
113,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,6,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
113,7,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
113,8,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
113,9,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
113,10,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
113,11,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
113,12,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
113,13,Secondary hypogonadism,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
115,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
116,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
116,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
117,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
117,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
117,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
117,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
118,1,Acquired immunodeficiency syndrome,Retroviral infections,Viral infectious disorders,Infec,N
118,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
118,3,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,4,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
118,5,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
118,6,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
119,1,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
119,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
119,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
119,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
119,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
119,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
120,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
120,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,3,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
121,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
121,2,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
121,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
122,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
122,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
122,3,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
122,4,Blood immunoglobulin A increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
122,5,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
122,6,Blood immunoglobulin M increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
122,7,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
122,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
122,9,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
122,10,CD4 lymphocytes,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,11,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
122,12,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
122,13,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
122,14,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
122,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
122,16,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
122,17,Headache,Headaches NEC,Headaches,Nerv,N
122,18,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
122,19,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
122,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,21,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
122,22,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
122,23,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
122,24,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
122,25,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
122,26,Viral hepatitis carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
122,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
125,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
125,4,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
125,5,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
125,6,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
125,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
125,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
125,10,Myopathy,Myopathies,Muscle disorders,Musc,N
125,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,12,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
125,13,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
126,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
126,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
126,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
126,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
126,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
126,6,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
127,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
128,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
128,2,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
128,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
128,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
129,2,Blood bicarbonate abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
129,3,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
129,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
129,5,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
129,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
130,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
130,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
130,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
130,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
131,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
132,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
132,4,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
132,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
133,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
133,3,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
133,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
133,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
133,6,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
133,7,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
133,8,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
133,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
134,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
135,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,1,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
136,2,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
136,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
136,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
136,5,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
136,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
136,7,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
136,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
137,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
137,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
137,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
137,4,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
137,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
137,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,7,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
137,8,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
137,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,10,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
137,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
137,12,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
137,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
138,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
138,5,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
138,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
138,7,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
138,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
140,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
140,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
140,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
140,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
140,5,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
140,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
140,7,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
140,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
142,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
142,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
142,3,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
143,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
143,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
143,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
143,4,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
143,5,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
143,6,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
143,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
143,8,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
143,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
143,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
144,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
144,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
144,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
145,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
145,4,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
145,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,6,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
146,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
146,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
146,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
146,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
147,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
148,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
151,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
152,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
152,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
152,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
153,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
154,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
154,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
154,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
155,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
155,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
155,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
156,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
156,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
156,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
157,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
158,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
158,2,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
158,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
158,4,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
158,5,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
158,6,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
158,7,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
158,8,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
158,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
158,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,12,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
159,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
159,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
160,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
160,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
161,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
162,1,Deafness,Hearing losses,Hearing disorders,Ear,N
163,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
164,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
165,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
165,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
166,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
167,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
167,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
167,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
167,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
168,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
168,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
169,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
170,1,Gingival hyperpigmentation,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
170,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
171,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
171,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
172,2,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
172,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
172,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
172,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
172,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,2,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
174,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
174,2,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
174,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
174,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
175,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
176,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
176,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
176,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
176,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
176,5,Mediastinal mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
176,6,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
176,7,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
177,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
177,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
178,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
178,2,Headache,Headaches NEC,Headaches,Nerv,N
178,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
178,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
178,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
180,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
180,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
181,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
181,2,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
181,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
181,4,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
181,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
181,6,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
182,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
182,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
183,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
183,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
184,1,Conduction disorder,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
184,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
185,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
185,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
185,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
185,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
185,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
185,6,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
185,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
186,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
186,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
186,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
186,7,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
186,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
186,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
187,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
187,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
187,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
188,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
188,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
188,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
189,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
190,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
190,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
190,3,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
190,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
190,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
190,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
190,8,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
190,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
190,10,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
190,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
191,1,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
191,2,Urine electrolytes increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
192,1,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
192,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
192,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
192,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
193,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
193,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
194,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
194,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
194,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
195,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
195,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
195,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
196,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
196,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
196,3,Myopathy,Myopathies,Muscle disorders,Musc,N
196,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
197,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
197,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
197,3,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
197,4,Myopathy,Myopathies,Muscle disorders,Musc,N
198,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
199,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
199,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
199,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
200,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
200,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
200,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
200,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
201,1,Circumoral oedema,Angioedemas,Angioedema and urticaria,Skin,N
201,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
201,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
201,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
203,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
203,2,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
203,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
203,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
204,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
205,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
205,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
205,3,Antisocial behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
205,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
206,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,1,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
207,2,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
207,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
208,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
209,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
209,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
209,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
210,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
211,1,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
212,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
212,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
212,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
212,4,Myopathy,Myopathies,Muscle disorders,Musc,N
213,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
213,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
213,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
214,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
217,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
217,2,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
217,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
217,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
217,5,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
218,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
218,2,Headache,Headaches NEC,Headaches,Nerv,N
219,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
219,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
220,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
220,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
220,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
220,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
221,2,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
222,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
222,2,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
222,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
223,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
223,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
224,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
224,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
225,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
226,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
227,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
228,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
229,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
229,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
229,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
229,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
231,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
231,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
231,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
232,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
232,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
232,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
233,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
233,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
233,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
236,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
236,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
236,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
237,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
238,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
238,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
239,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
240,2,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
240,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
241,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
241,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
241,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
241,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
242,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
242,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
243,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
243,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
244,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
244,5,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
244,6,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
244,7,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
244,8,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
245,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
245,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
246,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
247,1,Headache,Headaches NEC,Headaches,Nerv,N
247,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
248,2,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
248,3,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
248,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
248,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
248,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
249,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
250,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
251,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
251,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
252,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
252,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
252,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
253,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
253,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
253,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
254,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
254,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
254,3,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
254,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
254,5,Hypophosphataemic osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
254,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
254,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
255,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
255,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
256,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
256,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
256,3,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
256,4,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
256,5,Hyperphosphaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
256,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
257,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
258,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
259,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
260,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
260,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
261,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
262,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
262,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
263,1,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
263,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
264,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
264,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
265,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
265,2,Laryngeal erythema,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
265,3,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
265,4,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
265,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
265,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,7,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
265,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
266,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
266,2,Headache,Headaches NEC,Headaches,Nerv,N
266,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
267,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
267,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
267,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
268,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
269,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
269,2,Tuberculosis of eye,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
270,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
270,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
270,3,Laryngeal erythema,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
270,4,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
270,5,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
270,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
270,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,8,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
270,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
271,1,Hyperparathyroidism secondary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
271,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
272,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
272,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
272,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
272,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
273,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
273,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
274,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,3,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
275,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
276,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
277,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
277,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
277,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
277,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
277,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
277,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
277,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
279,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
280,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
281,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
281,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
281,3,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
281,4,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
283,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
284,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
285,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
286,1,Clinodactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
286,2,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
287,1,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
288,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
289,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
289,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
289,4,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
289,5,Nephritis,Nephritis NEC,Nephropathies,Renal,N
289,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
289,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,8,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
290,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
290,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
291,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
292,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
293,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
293,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
293,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
294,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
294,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
294,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
294,4,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
294,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
295,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
296,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
298,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
298,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
298,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
298,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
299,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
300,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
300,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
300,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
301,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
301,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
301,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
301,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
301,5,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
301,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
301,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
301,8,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
301,9,Lip exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
301,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
301,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,12,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
301,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
301,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,15,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,16,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
301,17,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
302,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
302,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
302,3,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
303,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
304,1,Acne,Acnes,Skin appendage conditions,Skin,N
304,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
304,3,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
304,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
304,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
305,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
305,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,5,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
306,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
306,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
306,3,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
306,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
306,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
306,6,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
307,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
308,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
308,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,1,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
310,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
310,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
311,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
311,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,3,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
312,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
313,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
313,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
314,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
314,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
314,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
315,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
316,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
316,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
316,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
316,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
316,5,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
316,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
316,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
318,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
319,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
320,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
320,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
321,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
321,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
321,4,Thought blocking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
322,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
322,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
322,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
323,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
323,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
323,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
323,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
323,5,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
323,6,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
323,7,Headache,Headaches NEC,Headaches,Nerv,N
323,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
323,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
323,10,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
324,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
325,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
325,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
327,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
327,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
328,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,2,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
329,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
329,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
329,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
329,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
329,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
329,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
330,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
330,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
330,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
332,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
333,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
334,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
335,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
335,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
335,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
335,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
336,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
336,3,Headache,Headaches NEC,Headaches,Nerv,N
336,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
336,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
337,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
337,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
337,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
337,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
337,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
337,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
338,1,Headache,Headaches NEC,Headaches,Nerv,N
338,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
338,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
338,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
339,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Eosinophilic pustular folliculitis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
340,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
340,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
341,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
341,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
341,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
341,4,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
341,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
341,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
341,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
342,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
343,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
344,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
345,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
346,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
346,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
347,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
348,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
349,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
350,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
350,2,Renal glycosuria,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
351,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
352,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
354,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
354,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
355,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
355,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
355,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
356,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
356,2,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
356,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
357,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
358,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
358,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
359,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
360,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
361,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
362,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
363,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
363,2,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
364,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
365,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
365,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
365,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
365,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
365,5,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
366,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
366,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
366,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
366,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
366,5,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
367,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
368,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
369,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
369,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
370,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
371,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
371,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
371,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
373,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
374,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
375,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
377,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
378,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
378,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
378,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
378,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
378,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
379,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
380,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
380,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
380,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
380,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
380,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
380,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
380,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
380,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
380,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
380,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
380,14,Headache,Headaches NEC,Headaches,Nerv,N
380,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
380,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,17,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
380,18,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,19,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,21,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
380,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
380,26,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
380,27,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
380,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
380,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,30,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
381,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
382,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
383,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
384,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
384,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
385,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
386,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
387,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
388,1,Aortic valve sclerosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
388,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
388,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
388,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
388,5,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
388,6,Complication of delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
388,7,Congenital anomaly in offspring,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
388,8,Congenital heart valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
388,9,Congenital pulmonary valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
388,10,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
388,11,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
388,12,Maternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
388,13,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
388,14,Neonatal respiratory arrest,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
388,15,Pulmonary valve sclerosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
388,16,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
388,17,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
389,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
389,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
390,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
391,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
391,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
392,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
392,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
392,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
393,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
394,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
395,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
395,2,Headache,Headaches NEC,Headaches,Nerv,N
395,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
395,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
395,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
396,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
396,2,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
396,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
396,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
396,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
397,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
397,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
397,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
398,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
398,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
398,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
398,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
399,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
399,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
400,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
400,2,Creatinine renal clearance,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
400,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
401,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
401,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
401,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
401,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
401,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
402,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
402,2,Dissociation,Dissociative states,Dissociative disorders,Psych,N
402,3,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
402,4,Electrocardiogram PR shortened,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
402,5,Headache,Headaches NEC,Headaches,Nerv,N
402,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
403,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
403,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
403,3,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
404,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
404,2,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
405,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
405,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
406,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
407,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
407,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
408,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
409,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
410,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
411,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
411,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
412,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
412,2,Headache,Headaches NEC,Headaches,Nerv,N
413,1,Trigeminal nerve disorder,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
414,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
414,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
414,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
414,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
414,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
415,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
416,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
416,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
417,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
418,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
418,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
419,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
419,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
419,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
419,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
419,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
420,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
420,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
420,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
422,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
422,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
422,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
422,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
422,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
423,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
425,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
425,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
425,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
425,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
425,5,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
425,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
425,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
425,8,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
425,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
426,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
427,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
428,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
428,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
428,3,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
428,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
428,5,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
429,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
429,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
429,3,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
429,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
429,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
429,6,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
429,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
430,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
431,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
431,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
431,3,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
431,4,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
431,5,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
431,6,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
431,7,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
431,8,Cloacal exstrophy,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
431,9,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
431,10,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
431,11,Congenital genital malformation,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
431,12,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
431,13,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
431,14,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
431,15,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,16,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,17,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,18,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
431,19,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
431,20,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,21,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,22,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
431,23,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
431,24,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
431,25,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
431,26,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
431,27,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
431,28,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
431,29,Musculoskeletal deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
431,30,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
431,31,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
431,32,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
431,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,34,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,35,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
431,36,Tethered cord syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
431,37,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
431,38,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
432,1,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
433,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
434,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
434,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
434,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
434,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
434,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
434,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
434,7,Headache,Headaches NEC,Headaches,Nerv,N
434,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
435,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
435,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
436,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
437,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
438,1,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
438,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
438,3,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
439,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
439,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
440,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
440,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
441,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
441,2,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
441,3,Dysentery,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
441,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
441,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
441,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
441,7,Shigella infection,Shigella infections,Bacterial infectious disorders,Infec,N
442,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
442,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
443,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
444,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
445,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
446,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
447,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
448,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
448,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
448,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
448,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
449,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
449,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
449,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
449,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
449,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
450,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
451,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
451,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
452,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
452,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
453,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
453,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
453,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
454,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
455,1,Ocular vasculitis,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
456,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
456,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
456,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
456,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
457,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
457,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
458,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
459,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
460,1,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
461,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
461,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
461,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
462,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
462,2,Headache,Headaches NEC,Headaches,Nerv,N
462,3,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
463,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
464,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
464,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
465,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
466,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
467,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
468,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
468,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
468,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
468,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
469,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
469,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
469,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
470,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
471,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
471,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
471,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
471,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
472,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
472,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
472,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
473,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
474,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
475,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
476,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
477,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
478,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
478,2,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
478,3,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
479,1,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
479,2,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
479,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
480,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
481,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
482,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
483,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
484,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
484,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
485,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
486,1,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
487,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
487,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
488,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
488,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
488,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
489,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
489,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
490,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
490,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
490,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
491,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
492,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
492,2,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
493,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
494,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
495,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
495,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
495,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
495,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
496,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
496,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
496,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
496,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
496,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
497,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
498,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
498,2,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
498,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
498,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
499,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
499,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,3,Syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
500,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
500,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
500,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
500,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
500,5,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
500,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
500,7,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
500,8,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
500,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
502,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
503,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
503,2,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
503,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
503,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
504,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
504,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
504,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
505,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
505,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
505,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
506,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,2,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
507,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
508,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,2,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
509,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
510,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
511,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
511,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
511,3,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
512,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
512,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
512,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
512,4,Terminal insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
513,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
514,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
514,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
514,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
515,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
515,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
516,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
516,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
516,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
517,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
517,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
517,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
519,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
520,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
520,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
521,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
522,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
523,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
524,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
524,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
524,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
526,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
526,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
526,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
527,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
528,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
528,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
528,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
528,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
528,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
529,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
529,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
530,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
531,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
531,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
531,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
531,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
531,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
531,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
532,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
533,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
533,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
533,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
533,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
533,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
534,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
534,2,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
534,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
534,4,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
535,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
535,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
535,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
535,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
535,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
536,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
536,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
537,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
538,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
539,1,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
539,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
540,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
540,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
541,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
541,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
541,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
541,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
541,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
541,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
542,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
542,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
542,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
543,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
544,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
545,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
546,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
547,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
547,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
547,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,4,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
547,5,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
547,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
547,7,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
547,8,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
547,9,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
548,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
549,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
550,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
551,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
551,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
551,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
552,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
555,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
556,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
556,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
557,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
558,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
559,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
559,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
560,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
560,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
560,3,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
560,4,Hyperphosphaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
560,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
560,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
561,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
561,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
561,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
561,4,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
561,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
562,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
562,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
562,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
562,4,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
562,5,Headache,Headaches NEC,Headaches,Nerv,N
562,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
562,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
563,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
563,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
563,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
564,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
564,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
565,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
565,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
566,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
566,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
566,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
566,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
566,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
566,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
566,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
566,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
566,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
566,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
567,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
567,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
567,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
568,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
569,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
571,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
572,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
572,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
572,3,Blood phosphorus abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
572,4,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
572,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
572,6,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
573,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
574,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
575,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
576,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
577,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
577,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
577,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
577,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
578,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
578,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
578,3,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
579,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
580,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
580,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
580,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
581,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
581,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
581,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
581,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
581,6,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
581,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
582,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
582,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
583,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
584,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
584,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
585,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
586,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
587,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
587,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
587,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
587,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
587,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
588,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
588,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
589,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
589,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
590,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
590,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
591,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
591,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
592,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
592,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
592,3,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
592,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
592,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
592,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
592,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
592,8,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
592,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
592,10,Megakaryocytes increased,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
592,11,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
592,12,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
593,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
593,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
594,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
595,1,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
596,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
596,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
597,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
597,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
599,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
601,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
601,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
601,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
601,4,Headache,Headaches NEC,Headaches,Nerv,N
601,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
601,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
601,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
602,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
602,3,Headache,Headaches NEC,Headaches,Nerv,N
602,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
603,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
603,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
604,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
604,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
605,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
606,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
607,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
608,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
609,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
610,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
611,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
613,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
613,2,Turner's syndrome,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
614,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
614,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
615,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
616,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
617,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
617,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
618,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
619,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
620,1,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
621,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
621,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
622,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
623,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
623,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
623,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
624,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
625,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
626,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
626,2,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
626,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
626,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
627,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
628,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
628,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
629,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
629,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
629,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
630,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
630,2,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
631,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
632,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
633,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
634,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
635,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
637,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
637,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
637,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
638,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
638,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
639,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
639,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
639,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
639,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
639,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
640,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
640,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
640,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
641,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
642,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
642,3,Migraine,Migraine headaches,Headaches,Nerv,N
642,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
642,5,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
643,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
643,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
644,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
646,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
647,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
647,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
648,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
648,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
649,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
650,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
651,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
651,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
652,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
653,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
653,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
654,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
655,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
655,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
655,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
655,4,Haemophilic arthropathy,Arthropathies NEC,Joint disorders,Musc,N
655,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
656,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
656,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
656,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
656,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
656,5,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
657,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
657,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
657,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
658,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
659,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
659,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
659,3,Headache,Headaches NEC,Headaches,Nerv,N
659,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
659,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
659,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
659,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
659,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
660,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
660,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
660,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
661,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
661,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
661,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
661,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
661,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
661,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
661,7,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
662,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
662,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
663,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
663,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
664,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
664,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
664,3,Headache,Headaches NEC,Headaches,Nerv,N
665,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
665,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
666,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
667,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
667,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
668,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
669,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,2,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
670,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
671,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
671,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
671,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
671,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
671,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
671,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
672,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
672,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
672,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
673,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
673,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
673,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
674,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
674,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
676,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
677,1,Immune reconstitution inflammatory syndrome associated Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
678,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
679,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
679,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
679,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
679,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
679,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
679,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
680,1,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
680,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
680,3,Palmoplantar keratoderma,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
680,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
680,5,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
680,6,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
681,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
681,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
681,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,6,Headache,Headaches NEC,Headaches,Nerv,N
681,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
681,8,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
681,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
681,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
681,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
681,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
681,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
681,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
681,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
682,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
683,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
683,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
684,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
685,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
686,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
687,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
687,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
688,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
688,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
688,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
688,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
688,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
688,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
688,7,Headache,Headaches NEC,Headaches,Nerv,N
688,8,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
688,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
688,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
688,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
688,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
688,13,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
688,14,Secondary syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
689,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
689,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
690,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
691,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
692,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
692,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
693,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
694,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
694,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
695,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
696,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
696,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
696,3,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
696,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
696,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
696,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
696,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
697,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
697,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
697,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
697,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
697,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
697,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
697,7,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
698,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
699,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
699,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
699,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
699,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
699,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
699,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
699,7,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
699,8,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
699,9,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
699,10,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
699,11,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
699,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
699,13,Thymus hypoplasia,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
700,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
700,2,Headache,Headaches NEC,Headaches,Nerv,N
700,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
700,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
701,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
702,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
703,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,2,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
704,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
705,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
706,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
706,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
706,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
707,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
707,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
708,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
709,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
710,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
711,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
711,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
712,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
712,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
712,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
712,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
713,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
713,2,Migraine,Migraine headaches,Headaches,Nerv,N
713,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
714,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
714,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
714,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
715,1,Headache,Headaches NEC,Headaches,Nerv,N
716,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
717,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
718,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
719,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
720,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
721,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
722,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
722,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
722,3,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
722,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
722,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
723,1,Amphetamines positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
723,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
723,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
723,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
724,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
724,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
724,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
724,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
724,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
724,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
725,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
725,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
726,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
726,2,Sleep talking,Parasomnias,Sleep disorders and disturbances,Psych,N
727,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
727,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
728,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
728,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
728,3,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
728,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
728,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
729,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
729,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
729,3,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
729,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
729,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
730,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
730,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
730,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
730,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
730,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
731,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
731,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
731,3,Headache,Headaches NEC,Headaches,Nerv,N
731,4,Hepatitis syphilitic,Treponema infections,Bacterial infectious disorders,Infec,N
731,5,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
731,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
731,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
731,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
731,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
731,10,Secondary syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
732,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
732,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
733,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
734,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
734,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
734,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
734,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
734,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
734,6,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
734,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
734,8,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
734,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
734,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
735,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
736,1,Acidosis hyperchloraemic,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
736,2,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
736,3,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
736,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
736,5,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
736,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
736,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
737,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
737,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
737,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
737,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
737,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
737,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
738,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
738,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
739,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
740,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
740,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
740,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
741,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
741,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
741,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
741,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
741,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
741,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
741,8,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
742,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
742,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
743,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
743,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
744,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
745,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
745,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
746,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
746,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,3,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
747,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
747,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
747,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
747,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
747,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
747,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
747,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
749,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
750,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
751,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
752,1,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
752,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
753,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
753,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
754,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
755,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
755,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
756,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
757,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
758,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
758,2,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
759,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
759,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
759,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
760,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
761,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
761,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
761,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
762,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
763,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
764,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
765,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
765,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
765,3,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
765,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
765,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
765,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
765,7,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
765,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
765,10,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
765,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,12,Vascular compression,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
766,1,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
767,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
767,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
767,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
767,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
768,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
768,2,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
768,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
769,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
770,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
770,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
771,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
771,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
771,3,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
771,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
771,5,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
771,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
772,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
772,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
773,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
773,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
773,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
773,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
773,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
774,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
774,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
774,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
775,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
775,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
775,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
775,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
775,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
775,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
775,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
775,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
776,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
777,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
777,2,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
778,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
778,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
778,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
778,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
779,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
780,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
780,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
780,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
780,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
781,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
781,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
781,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
782,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
782,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
782,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
782,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
782,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
782,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
782,7,Headache,Headaches NEC,Headaches,Nerv,N
782,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
783,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
783,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
784,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
785,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
786,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
787,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
788,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
789,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
789,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
790,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
790,2,Haemophilia,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
791,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
792,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
793,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
794,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
795,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
795,2,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
796,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
796,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
796,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
797,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
798,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
799,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
800,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
800,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
801,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
801,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
801,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
801,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
802,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
802,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
802,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
803,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
804,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
804,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
804,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
804,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
804,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
805,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
805,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
806,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
806,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
806,3,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
807,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
808,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
808,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
808,3,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
809,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
809,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
809,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
810,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
810,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
810,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
810,4,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
810,5,Headache,Headaches NEC,Headaches,Nerv,N
810,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
810,7,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
810,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
810,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
811,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
811,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
811,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
812,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
813,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
814,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
814,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
814,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
815,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
815,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
816,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
816,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
817,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
817,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
818,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
819,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
820,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
820,2,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
821,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
821,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
822,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
822,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
822,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
822,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
823,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
824,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
824,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,3,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
824,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
825,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
826,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
827,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
828,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
829,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
829,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
829,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
830,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
830,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
830,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
830,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
831,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
832,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
833,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
833,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
834,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
835,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
836,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
836,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
837,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
838,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
839,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
839,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
839,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
841,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
841,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
841,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
841,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
841,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
841,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
841,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
841,8,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
841,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
841,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
841,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
842,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
842,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
842,3,Premature baby death,Death and sudden death,Fatal outcomes,Genrl,Y
843,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
844,1,Nasal odour,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
844,2,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
845,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
846,1,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
847,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
848,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
849,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
849,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
850,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
850,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
851,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
852,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
853,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
853,2,Idiopathic angioedema,Angioedemas,Angioedema and urticaria,Skin,N
853,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
854,1,Endocrine ophthalmopathy,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
855,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
856,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
856,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
857,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,3,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
858,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
858,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
859,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
859,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
859,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
860,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
860,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
860,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
860,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
860,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
860,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,7,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
860,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
860,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
860,10,Myopathy,Myopathies,Muscle disorders,Musc,N
860,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
860,12,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
860,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
860,14,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
861,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
862,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
863,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
864,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
865,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
866,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
867,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
868,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
868,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
868,3,Headache,Headaches NEC,Headaches,Nerv,N
868,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
868,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
868,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
868,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
868,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
869,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
869,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
869,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
870,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
871,1,ACTH stimulation test abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
871,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
871,3,Blood corticotrophin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
871,4,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
871,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,1,Amniotic band syndrome,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
872,2,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
872,3,Neonatal aspiration,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
872,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
872,5,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
872,6,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
872,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
873,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
874,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
874,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
875,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
875,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
875,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
875,5,Viral load decreased,Virus identification and serology,Microbiology and serology investigations,Inv,N
876,1,Congenital teratoma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
876,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
876,3,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
876,4,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
876,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
876,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
877,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
877,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
878,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
878,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
879,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
879,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
879,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,1,Acne,Acnes,Skin appendage conditions,Skin,N
881,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
881,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
881,4,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
882,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
883,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
883,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
884,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
884,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
884,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
885,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
885,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
885,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
886,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
886,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
886,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
887,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
888,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
889,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
889,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
889,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
889,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
889,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
890,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
890,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
890,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
890,4,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
890,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
890,6,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
891,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
891,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
891,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
892,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
893,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
894,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
895,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
896,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
897,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
898,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
899,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
902,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
903,1,Intervertebral disc operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
904,1,Mitochondrial myopathy acquired,Myopathies,Muscle disorders,Musc,N
905,1,Mitochondrial myopathy acquired,Myopathies,Muscle disorders,Musc,N
906,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
907,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
907,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
910,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
911,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
911,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
912,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
912,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
912,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
913,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
913,2,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
913,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
913,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
913,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
913,6,Prophylaxis against HIV infection,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
913,7,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
914,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
914,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
914,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
914,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
914,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
914,6,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
914,7,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
915,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
915,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
915,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
916,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
916,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
916,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
917,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
917,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
918,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
918,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
918,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
918,4,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
919,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
919,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
919,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
920,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
921,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
921,2,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
921,3,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
921,4,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
921,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
921,6,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
922,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
922,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
922,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
922,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
922,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
922,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
922,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
922,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
922,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
923,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
924,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
925,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
925,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
925,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
926,1,Congenital genitourinary abnormality,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
927,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
928,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
929,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
929,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
930,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
930,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
931,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
932,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
932,2,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
932,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
933,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
933,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
934,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,1,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
936,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
937,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
939,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
939,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
939,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
940,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
941,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
941,2,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
941,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
941,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
941,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
941,6,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
941,7,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
941,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
941,9,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
941,10,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
941,11,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
941,12,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
941,13,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
941,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
941,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
941,16,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
941,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
941,18,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
942,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
943,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
943,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
943,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
945,1,Headache,Headaches NEC,Headaches,Nerv,N
946,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
946,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
947,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
947,2,Ectopic pregnancy with contraceptive device,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
947,3,Ruptured ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
947,4,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
948,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,2,Ectopic pregnancy with contraceptive device,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
948,3,Ruptured ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
948,4,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
949,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
949,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
949,3,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
950,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
950,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
951,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
951,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
951,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
952,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
952,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
953,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
953,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
954,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
955,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
955,2,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
956,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
956,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
956,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
957,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
958,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
959,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
959,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
959,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
959,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
960,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
960,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
961,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
962,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
962,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
963,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
963,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
963,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
964,1,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
964,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
965,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
965,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
965,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
966,1,Gastrectomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
966,2,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
966,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
966,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
967,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
967,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
968,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
969,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
969,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
970,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
971,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
971,3,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
972,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
973,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
974,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
975,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
975,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
975,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
975,4,Headache,Headaches NEC,Headaches,Nerv,N
975,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
975,6,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
975,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
976,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
976,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
976,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
976,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
976,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
976,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
977,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
977,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
977,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
977,5,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
977,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
977,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
977,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
978,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
979,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
980,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
981,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
981,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
981,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
981,4,Headache,Headaches NEC,Headaches,Nerv,N
981,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
981,6,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
982,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
982,2,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
982,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
983,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
983,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
984,1,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
985,1,Ammonia increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
985,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
985,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
986,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
986,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
987,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
988,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
988,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
988,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
988,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
988,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
989,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
990,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
990,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
991,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
992,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
993,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
994,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
995,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
996,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
996,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
997,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
997,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
997,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
998,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
999,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
999,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1000,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1000,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1000,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1000,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1000,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1000,6,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1000,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1000,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1000,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1000,10,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1000,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1001,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1001,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1001,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1001,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1002,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1002,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1002,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1003,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1004,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1004,2,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1004,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1004,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1004,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1005,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1005,2,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1005,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1005,4,Urine phosphorus abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1006,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1006,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1006,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1006,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1006,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1006,6,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1006,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1006,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1006,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1006,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1006,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1006,12,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1006,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1007,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
1007,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1007,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1008,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1009,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1009,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1010,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
1010,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1011,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1012,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1012,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1013,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1013,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1014,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1014,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1014,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1014,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1015,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1015,2,Idiopathic angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1015,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1016,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1016,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1016,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1017,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1018,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1018,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1019,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1019,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1019,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1019,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1019,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1020,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1020,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1020,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1020,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1021,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1021,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1021,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1021,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1021,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1021,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1021,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1021,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1021,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1022,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1022,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1023,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1024,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1025,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1025,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1026,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1027,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1028,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1028,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1028,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1029,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1029,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1029,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1029,4,Macular pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1029,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1030,1,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1030,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1031,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1031,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1032,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1033,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1033,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1033,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1034,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1035,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1036,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1036,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1037,1,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1037,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1038,1,Jejunostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1039,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
1039,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1040,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1040,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1040,3,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1041,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1041,2,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1042,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1043,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1044,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1045,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1046,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1047,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1047,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1048,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1049,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1050,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1050,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1051,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1051,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1052,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1053,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1053,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1054,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1055,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1056,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1057,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1057,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1058,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1059,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1059,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1060,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1060,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1060,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1061,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1061,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1062,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1063,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1063,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1063,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1064,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1064,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1065,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1066,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1066,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1066,3,Multiple pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1066,4,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1066,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1068,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1068,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1068,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1068,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1068,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1068,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1068,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1068,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1068,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,10,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1069,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1070,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1070,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1071,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1072,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1073,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1073,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1073,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1074,1,Headache,Headaches NEC,Headaches,Nerv,N
1074,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1074,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1074,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1074,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1074,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1075,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1075,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1075,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1076,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1076,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1076,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1077,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1077,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1077,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1077,4,Headache,Headaches NEC,Headaches,Nerv,N
1077,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1077,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1077,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1077,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1078,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1078,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1078,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1078,4,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1079,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1080,1,Acne,Acnes,Skin appendage conditions,Skin,N
1080,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1081,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1081,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1081,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1082,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1082,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1083,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1083,2,Headache,Headaches NEC,Headaches,Nerv,N
1083,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1083,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1084,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1085,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1085,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1085,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1085,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1085,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1085,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1085,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1086,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1086,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1087,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1087,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1087,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1088,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
1089,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1090,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1090,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1090,3,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
1090,4,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1091,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1092,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1092,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1093,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1094,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1095,1,Blood HIV RNA,Virus identification and serology,Microbiology and serology investigations,Inv,N
1095,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1096,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1097,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1097,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1098,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1098,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1098,3,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
1099,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1099,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1100,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1100,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1101,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1102,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1102,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1103,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1104,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1104,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1104,3,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1105,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1105,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1106,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1107,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1108,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1109,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1109,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1109,4,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1109,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1109,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1110,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1110,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1110,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1110,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1112,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1114,1,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1114,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1114,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1114,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1115,1,Alcohol use,Alcohol product use,Lifestyle issues,SocCi,N
1115,2,Alcoholism,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1115,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1115,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1115,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1116,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1116,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1117,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1117,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1118,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1118,2,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1118,3,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1118,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1119,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1120,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1121,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1121,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1121,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1122,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1122,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1123,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1123,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1123,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1123,4,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
1123,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1124,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1124,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1124,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1125,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1126,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1126,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1127,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1128,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1129,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1130,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1131,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1132,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1133,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1134,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1135,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1135,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1136,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1137,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1137,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1137,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1137,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1138,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1138,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1139,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1139,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1140,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1141,1,Ectopic pregnancy with contraceptive device,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1141,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1141,3,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1141,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1141,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1141,6,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1141,7,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1141,8,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1142,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1142,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1143,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1143,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1143,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1143,4,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1143,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1144,1,Ectopic pregnancy with contraceptive device,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1144,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1144,3,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1144,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1144,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1144,6,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1144,7,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1144,8,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1145,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1145,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1146,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1146,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1146,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1146,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1147,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1148,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1149,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1149,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1149,3,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1149,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1149,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1149,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1150,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1150,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1151,1,AIDS cholangiopathy,Retroviral infections,Viral infectious disorders,Infec,N
1151,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1151,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1151,4,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1151,5,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1151,6,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1151,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1151,8,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
1151,9,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1151,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1151,11,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1151,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1151,13,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1152,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1153,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1153,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1154,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1154,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1154,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1154,4,Neuropsychiatric syndrome,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1154,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1155,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1155,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1156,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1157,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1158,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1158,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1159,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1159,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1160,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1160,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1160,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1161,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1161,2,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1162,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1163,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1163,2,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1164,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1164,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1165,2,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1166,1,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1167,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1168,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1169,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1170,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1170,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1171,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1171,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1172,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1172,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1172,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1173,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1173,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1173,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1173,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1174,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1174,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1175,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1175,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1175,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1175,4,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1176,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1177,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1177,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1177,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1178,1,Headache,Headaches NEC,Headaches,Nerv,N
1179,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1180,1,Headache,Headaches NEC,Headaches,Nerv,N
1180,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1180,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1180,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1181,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1181,2,Headache,Headaches NEC,Headaches,Nerv,N
1181,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1182,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1182,2,Headache,Headaches NEC,Headaches,Nerv,N
1182,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1183,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1183,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1183,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1184,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1185,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1186,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1186,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1187,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1187,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1187,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1188,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1188,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1188,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1189,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1190,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1190,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1190,3,Pharyngeal abscess,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1191,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1191,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1191,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1191,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1191,5,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1191,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1191,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1192,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1192,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1193,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1193,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1193,3,Headache,Headaches NEC,Headaches,Nerv,N
1194,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1194,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1194,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1194,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1194,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1195,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1196,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1196,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1197,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1197,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1198,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1198,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1199,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1200,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1200,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1200,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1201,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1201,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1202,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1202,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1203,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1203,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1203,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1203,4,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1204,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1205,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1205,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1206,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1206,2,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1207,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1208,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1208,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1209,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1210,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1210,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1210,3,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1210,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1210,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1211,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1211,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1212,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1212,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1212,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1213,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1213,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1213,3,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1213,4,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1214,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1214,2,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1215,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1216,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1216,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1217,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1217,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1217,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1218,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1219,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1220,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1220,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1221,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1222,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1222,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1223,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1223,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1223,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1223,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1224,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1225,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1226,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1227,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1227,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1228,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1228,2,Headache,Headaches NEC,Headaches,Nerv,N
1229,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1229,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1230,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1230,2,Hepatitis syphilitic,Treponema infections,Bacterial infectious disorders,Infec,N
1230,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1230,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1231,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1233,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1233,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1233,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1234,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1235,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1236,1,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1236,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1236,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1236,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1237,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,Y
1237,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1237,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1237,4,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1237,5,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1237,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1237,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1237,8,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1237,9,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1237,10,Hydrops foetalis,Foetal complications NEC,Foetal complications,Preg,N
1237,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1237,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1237,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1237,14,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1237,15,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
1238,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1238,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1238,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1238,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1239,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1239,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1240,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1241,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1241,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1242,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1243,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1243,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1244,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1245,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1246,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1246,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1246,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1246,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1246,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1247,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1248,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1249,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1251,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1252,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1253,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1254,1,Headache,Headaches NEC,Headaches,Nerv,N
1255,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1255,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1255,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1255,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1256,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1257,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1258,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1258,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1258,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1258,4,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1259,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1260,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1261,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1262,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1263,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1264,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1265,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1266,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1266,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1267,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1267,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1267,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1267,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1268,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1269,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1269,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1269,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1269,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1269,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1269,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1270,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1271,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1272,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1272,2,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1273,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1273,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1274,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1275,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1276,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1277,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1278,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1279,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1280,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1281,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1282,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1282,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1283,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1283,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1283,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1284,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1284,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1285,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1286,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1286,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1287,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1287,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1288,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1288,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1288,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1289,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1290,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1292,1,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1292,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1294,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1295,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1295,2,HIV viraemia,Retroviral infections,Viral infectious disorders,Infec,N
1295,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1295,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1295,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1296,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1296,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1297,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1297,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1298,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1299,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1299,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1299,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1300,1,Anal paraesthesia,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1300,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1301,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1302,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1302,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1302,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1303,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1303,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1304,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1304,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1305,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1305,2,Headache,Headaches NEC,Headaches,Nerv,N
1305,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1306,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1306,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1307,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1307,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1307,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1307,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1307,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1307,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1307,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1307,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1308,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1308,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1309,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1309,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1309,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1310,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1310,2,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1310,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1310,4,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1311,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1311,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1312,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1312,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1312,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1313,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1313,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1313,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1314,1,Gingivitis ulcerative,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1314,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1315,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1315,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1315,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1315,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1316,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1317,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1318,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1318,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1319,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1319,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1319,3,Headache,Headaches NEC,Headaches,Nerv,N
1320,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1320,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1321,1,Tongue neoplasm,Lip and oral cavity neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1322,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1323,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1325,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1325,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1325,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1325,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1325,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1325,6,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1325,7,Headache,Headaches NEC,Headaches,Nerv,N
1325,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1325,9,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1325,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1325,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1325,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1325,13,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1325,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1325,15,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1325,16,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1325,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1325,18,Pharyngitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1325,19,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1325,20,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1326,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1327,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1327,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1328,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1328,2,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1329,1,Acute HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1329,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1329,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1330,1,Acute HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1330,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1331,1,Acute HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1331,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1331,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1332,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1333,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1334,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1335,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1335,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1335,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1335,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1336,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1337,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1338,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1339,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1339,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1340,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1341,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1342,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1342,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1343,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1344,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
1344,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1345,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1346,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
1346,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1347,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
1347,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1348,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1348,2,Neurosurgery,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1349,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1350,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1352,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1352,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1352,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1352,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1352,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1352,6,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1352,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1352,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1352,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1352,10,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1353,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1353,2,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
1353,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1354,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1354,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1354,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1354,4,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1354,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1354,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1355,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1355,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1355,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1355,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1355,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1356,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1356,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1357,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1357,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1357,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1358,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1359,1,Metastatic lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1359,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1360,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1360,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1360,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1360,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1360,5,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1361,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1362,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1362,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1363,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1363,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1364,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1364,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1364,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1365,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1365,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1365,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1366,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1367,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1367,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1368,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1368,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1369,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1370,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1371,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1371,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1372,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1372,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1372,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1373,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1373,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1374,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1375,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1376,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1377,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1377,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1377,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1378,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
1378,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1379,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1379,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1380,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1380,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1381,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1381,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1381,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1381,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1381,5,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1382,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1383,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1383,2,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1384,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1385,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1385,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1386,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1386,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1387,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1387,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1387,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1387,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1388,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1388,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1389,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1389,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1390,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1390,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1391,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1392,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1393,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1394,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1394,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1394,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1394,4,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1395,1,Headache,Headaches NEC,Headaches,Nerv,N
1395,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1396,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1396,2,Headache,Headaches NEC,Headaches,Nerv,N
1396,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1396,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1396,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1397,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1397,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1397,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1398,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1398,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1399,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1400,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1401,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1402,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1403,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
1403,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1404,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1404,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1404,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1405,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1406,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1406,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1407,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1407,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1408,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1409,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1410,1,Acute HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1410,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,3,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1411,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1412,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1412,2,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
1413,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1414,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1414,2,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1415,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1415,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1416,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1416,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1416,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1417,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1417,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1418,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1419,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1419,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1420,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1421,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1421,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1422,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1422,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1422,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1422,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1423,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1423,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1423,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1424,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1424,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1425,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1425,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1426,1,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1426,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1427,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1427,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1428,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1429,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1429,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1430,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1430,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1431,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1431,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1432,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1432,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1432,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1432,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1433,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1433,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1433,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1433,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1434,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1434,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1434,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1435,1,Involuntary commitment,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1436,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1437,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1438,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1438,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1439,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1440,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1441,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1442,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1443,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1443,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1443,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1444,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1445,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1446,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1446,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1446,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1446,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1447,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1448,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1448,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1449,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1449,2,Headache,Headaches NEC,Headaches,Nerv,N
1449,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1450,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1450,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1450,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1451,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1452,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1453,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1453,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1454,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1455,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1456,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1457,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1458,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1458,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1458,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1458,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1460,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1461,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1461,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1462,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1463,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1463,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1464,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1465,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1465,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1466,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1466,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1467,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1468,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1469,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1469,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1470,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1470,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1470,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1471,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1471,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1471,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1471,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1471,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1471,6,Headache,Headaches NEC,Headaches,Nerv,N
1471,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1471,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1471,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1471,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1472,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1473,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1473,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1474,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1475,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1475,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1476,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1476,2,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1476,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1477,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1477,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1477,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1477,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1477,5,Headache,Headaches NEC,Headaches,Nerv,N
1477,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1477,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1477,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1477,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1478,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1478,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1478,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1478,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1479,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1479,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1479,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1479,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1480,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1480,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1481,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1482,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1482,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1483,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1484,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1485,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1486,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1487,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1487,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1487,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1488,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1489,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1490,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1491,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1492,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1493,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1494,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1495,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1496,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1496,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1496,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1497,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1498,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1498,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1499,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1499,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1500,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1501,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1502,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1502,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1503,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1504,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1504,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1505,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1506,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1506,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1506,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1506,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1506,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1506,6,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1506,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1506,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1507,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1507,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1507,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1508,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1509,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1509,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1509,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1510,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1510,2,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1510,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1511,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1511,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1511,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1512,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1513,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1513,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1513,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1514,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1514,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1514,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1514,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1515,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1515,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1515,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1515,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1515,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1515,6,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1515,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1515,8,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1516,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1516,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1516,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1517,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1518,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1519,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1520,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1520,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1521,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1521,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1521,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1521,4,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1522,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1523,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1523,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1523,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1524,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1524,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1524,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1524,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1525,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1525,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1525,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1526,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1526,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1527,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1527,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1527,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1527,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1527,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1527,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1527,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1528,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1529,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1530,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1531,1,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
1531,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1531,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1531,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1532,1,Headache,Headaches NEC,Headaches,Nerv,N
1532,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1532,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1532,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1533,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
1533,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1533,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1534,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1535,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1535,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1536,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1536,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1536,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1536,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1536,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1537,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1537,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1538,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1539,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1540,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1540,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1540,5,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1540,6,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1540,7,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1541,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1541,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1541,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1542,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1543,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1543,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1543,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1543,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1543,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1544,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1544,2,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1544,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1544,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1545,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1546,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1547,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1547,2,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1547,3,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1548,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1549,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1550,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1550,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1550,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1550,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1550,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1550,6,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1550,7,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1550,8,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1551,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1551,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1551,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1551,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1551,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1551,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1551,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1551,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1552,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1552,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1553,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1554,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1554,2,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1554,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1555,1,Headache,Headaches NEC,Headaches,Nerv,N
1555,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1556,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1556,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1557,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1558,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1559,1,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1560,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1561,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1561,2,Headache,Headaches NEC,Headaches,Nerv,N
1561,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1562,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1562,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1562,3,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1562,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1563,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1563,2,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1564,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1564,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1564,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1564,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1564,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1565,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1565,2,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1565,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1565,4,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1566,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1566,2,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1566,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1567,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1567,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1567,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1567,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1567,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1568,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1568,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1569,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1569,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1569,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1570,1,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1570,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1570,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1571,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1571,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1571,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1571,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1571,5,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1571,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1572,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1572,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1573,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1574,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1575,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1575,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1575,3,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1576,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1577,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1577,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1577,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1577,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1577,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1577,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1577,7,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1577,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1578,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1579,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1580,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1580,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1581,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1582,1,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1583,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1584,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1584,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1585,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1586,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1587,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1588,1,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1589,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1590,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1591,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1592,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1592,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1592,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1593,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1593,2,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1593,3,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1594,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1594,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1595,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1595,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1596,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1597,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1597,2,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
1598,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1598,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1599,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1599,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1599,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1600,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1600,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1600,3,Headache,Headaches NEC,Headaches,Nerv,N
1600,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1600,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1601,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1601,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1601,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1602,1,Alveolar osteitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1602,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1603,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1603,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1604,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1604,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1604,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1605,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1605,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1605,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1606,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1607,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1608,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1608,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1608,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1608,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1609,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1610,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1610,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1611,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1612,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1613,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1614,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1615,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1616,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1617,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1618,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1619,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1620,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1620,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1620,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1621,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1621,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1621,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1622,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1623,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1624,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1625,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1626,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1627,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1628,1,Headache,Headaches NEC,Headaches,Nerv,N
1628,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1628,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1628,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1629,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1629,2,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
1629,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1629,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1630,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1631,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1631,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1632,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1632,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1632,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1632,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1633,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1634,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1634,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1634,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1634,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1635,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1635,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1636,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1637,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1638,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1638,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1639,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1639,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1639,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1640,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1641,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1641,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1642,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1642,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1643,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1644,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1645,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1646,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1647,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1648,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1649,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1650,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1651,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1651,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1652,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1652,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1653,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1653,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1654,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1654,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1655,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1655,2,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1656,1,Gastric bypass,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1656,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1657,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1658,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1658,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1659,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1659,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1660,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1660,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1661,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1662,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1662,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1662,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1662,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1662,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1663,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1664,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1664,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1665,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1665,2,Foetal megacystis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1665,3,Ureteral disorder,Ureteric disorders NEC,Ureteric disorders,Renal,N
1666,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1666,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1667,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1667,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1668,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1669,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1669,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1669,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1669,4,Headache,Headaches NEC,Headaches,Nerv,N
1669,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1669,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1669,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1669,8,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1670,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1670,2,Headache,Headaches NEC,Headaches,Nerv,N
1670,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1671,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1672,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1672,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1673,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1674,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1675,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1675,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1676,1,Breast engorgement in newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1676,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1676,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1677,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1678,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1679,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1680,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1680,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1681,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1682,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1683,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1683,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1684,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1684,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1685,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1685,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1686,1,Headache,Headaches NEC,Headaches,Nerv,N
1687,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1687,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1688,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1689,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1690,1,Headache,Headaches NEC,Headaches,Nerv,N
1690,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1691,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1691,2,Quarantine,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1692,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1692,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1693,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1694,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1695,1,Laryngectomy,Laryngeal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1696,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1696,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1697,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1698,1,Headache,Headaches NEC,Headaches,Nerv,N
1699,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1699,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1700,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1701,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1701,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1702,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1702,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1703,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1704,1,Living in residential institution,Housing circumstances,Economic and housing issues,SocCi,N
1705,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1705,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1706,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1706,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1706,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1706,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1706,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1706,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1707,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1707,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1707,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,5,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1707,6,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1708,1,Apgar score abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1708,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1708,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1708,4,Meconium aspiration syndrome,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1708,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1709,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1709,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1710,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1710,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1711,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1711,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1712,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1712,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1712,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1712,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1712,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1712,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1713,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1713,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1714,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1715,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1715,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1715,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1715,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1715,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1715,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1716,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1717,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1717,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1717,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1717,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1717,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1718,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1719,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1719,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1719,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1719,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1720,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1721,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1721,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1722,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1722,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1723,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1723,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1724,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1725,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1726,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1727,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1727,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1727,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1728,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1728,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1729,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1729,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1730,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1730,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1731,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1732,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1732,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1732,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1733,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1734,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1735,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1736,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1736,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1736,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
1736,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1737,1,Craniofacial deformity,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1737,2,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1737,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1737,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1737,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1737,6,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1737,7,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
1738,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1739,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1740,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1741,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1742,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1742,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1743,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1743,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1744,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1744,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1744,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1744,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1744,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1744,6,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1744,7,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1744,8,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1745,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1746,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1746,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1747,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1747,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1747,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1747,4,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1747,5,Physical assault,Criminal activity,Legal issues,SocCi,N
1748,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1749,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1750,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1751,1,Headache,Headaches NEC,Headaches,Nerv,N
1751,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1752,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1752,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1752,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1753,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1753,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1753,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1753,4,Psychological factor affecting medical condition,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1753,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1754,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1754,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1754,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1754,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1754,5,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1755,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1755,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1755,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1755,4,Rest regimen,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1756,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1757,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1758,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1759,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1760,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1760,2,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1761,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1762,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1763,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1764,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1765,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1765,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1765,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1765,4,Headache,Headaches NEC,Headaches,Nerv,N
1765,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1765,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1765,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1765,8,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1765,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1765,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1765,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1766,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1767,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1767,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1768,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1769,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1769,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1769,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1769,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1769,5,Headache,Headaches NEC,Headaches,Nerv,N
1769,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1769,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1769,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1769,9,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1769,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1769,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1769,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1770,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1770,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1771,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1771,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1771,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1771,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1771,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1771,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1771,7,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1771,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1772,1,Headache,Headaches NEC,Headaches,Nerv,N
1773,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1773,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1773,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1773,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1774,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1774,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1775,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1776,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1777,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1777,2,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1777,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1777,4,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1777,5,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1777,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1778,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1778,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1779,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1780,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1780,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1780,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1781,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1781,2,Renal disorder in pregnancy,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1782,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1783,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1783,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1783,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1784,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1785,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1786,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1787,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1787,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1787,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1787,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1787,5,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1787,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1787,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1788,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1789,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1790,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1790,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1791,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1792,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1792,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1793,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1793,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1794,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1794,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1795,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1795,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1796,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1797,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1798,1,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1798,2,Choluria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1798,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1798,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1798,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1798,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1799,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1800,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
1800,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1801,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1802,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1803,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1804,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1804,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1804,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1804,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1805,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1805,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1805,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1805,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1805,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1805,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1806,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1807,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1808,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1808,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1809,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
1809,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1809,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1809,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1810,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1810,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1810,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1811,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1811,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1811,3,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1811,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,1,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1812,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1812,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1813,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1814,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1814,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1815,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1815,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1816,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1817,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1818,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1818,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1819,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1819,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1819,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1819,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1820,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1820,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1821,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1822,1,Body fat disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1823,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1823,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1824,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1824,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1825,1,CD4 lymphocytes abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1826,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1826,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1826,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1826,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1826,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1826,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1827,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1827,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1828,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1829,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1830,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1831,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1832,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1833,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1834,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1835,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1836,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1836,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1837,1,Headache,Headaches NEC,Headaches,Nerv,N
1838,1,Dissociative disorder,Dissociative states,Dissociative disorders,Psych,N
1839,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1840,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1841,1,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1841,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1841,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1842,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1842,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1842,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1842,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1842,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1843,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1843,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1843,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1844,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1845,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1846,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1847,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1848,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1849,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1849,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1849,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1849,4,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1849,5,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1849,6,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1850,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1850,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1850,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1851,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1852,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1853,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1854,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1855,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1855,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1855,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1855,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1856,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1857,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1858,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1859,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1860,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1861,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1861,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1861,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1861,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1861,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1861,6,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1861,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1862,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1862,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1862,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1862,4,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1863,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1864,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1865,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1865,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1865,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1865,4,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1866,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1867,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1868,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1869,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1869,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1870,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1870,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1870,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1870,4,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1871,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1872,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1873,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1874,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1874,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1875,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1875,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1875,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1875,4,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1876,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1877,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1878,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1879,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1880,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1881,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1881,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1881,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1882,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1882,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1883,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1884,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1884,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1884,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1885,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1886,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1886,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1887,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1888,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1889,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1890,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1891,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1892,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1892,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1893,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1894,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1894,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1894,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1895,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1896,1,Acne,Acnes,Skin appendage conditions,Skin,N
1896,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1897,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1898,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1899,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1900,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1900,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1900,3,Headache,Headaches NEC,Headaches,Nerv,N
1900,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1900,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1900,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1900,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1900,8,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1900,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1900,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1901,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1902,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1902,2,Hypophosphataemic osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1902,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1902,4,Pseudofracture,Fractures NEC,Fractures,Musc,N
1903,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1903,2,Hypophosphataemic osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1903,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1904,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1905,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1906,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1907,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1908,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1909,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1910,1,HIV viraemia,Retroviral infections,Viral infectious disorders,Infec,N
1910,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1910,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1911,1,Physical product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1912,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1912,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1913,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1914,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1915,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1915,2,Headache,Headaches NEC,Headaches,Nerv,N
1916,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1917,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1918,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1919,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1919,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1920,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1920,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1921,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1922,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1923,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1924,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1925,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1926,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1927,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1927,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1928,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1929,1,HIV viraemia,Retroviral infections,Viral infectious disorders,Infec,N
1929,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1929,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1929,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1929,5,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1930,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1931,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
1931,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1931,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1932,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1933,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1934,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1935,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1936,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1937,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1937,2,Viral load,Virus identification and serology,Microbiology and serology investigations,Inv,N
1938,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1938,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1938,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1939,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1940,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1940,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1941,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1942,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1943,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1943,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1944,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1944,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1944,3,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1944,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1945,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1946,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1947,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1947,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1947,3,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1948,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1948,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1949,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1949,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1950,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1950,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1951,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1951,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1951,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1952,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1952,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1953,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1953,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1954,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1954,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1954,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1954,4,Genital infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1954,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1954,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1954,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1954,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1954,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1954,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1954,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1955,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1955,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1956,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1956,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1956,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1956,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1957,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1957,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1958,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1958,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1958,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1959,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1959,2,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1959,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1960,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1960,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1960,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1961,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1961,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1961,3,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1961,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,5,Vertical infection transmission,Infectious transmissions,Ancillary infectious topics,Infec,N
1961,6,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1962,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1963,1,Headache,Headaches NEC,Headaches,Nerv,N
1963,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1964,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1964,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1965,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1966,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1966,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1967,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1968,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1968,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1968,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1968,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1969,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1970,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1971,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1972,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1973,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1974,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1975,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1976,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1977,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1977,2,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1978,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1978,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1979,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1979,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1980,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1980,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1980,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1980,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1980,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1980,6,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1980,7,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1980,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1980,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,10,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1980,11,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1981,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1982,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1982,2,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1983,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1984,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1984,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1984,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1985,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1986,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1986,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1987,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1988,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1989,1,Blood HIV RNA below assay limit,Virus identification and serology,Microbiology and serology investigations,Inv,N
1990,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1990,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1991,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1991,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1991,3,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1992,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1992,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1992,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1993,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1994,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1995,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1996,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1997,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1997,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1997,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1998,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1999,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1999,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1999,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2000,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2000,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2000,3,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2000,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2000,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2000,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2000,7,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2000,8,Headache,Headaches NEC,Headaches,Nerv,N
2000,9,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2000,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
2000,11,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2000,12,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2001,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2002,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2003,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2003,2,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2004,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2004,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2005,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2006,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2006,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2007,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2008,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2008,2,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2009,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2010,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2011,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2012,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2013,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2015,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2016,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2017,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2017,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2017,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2017,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2018,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2019,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2020,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2021,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2022,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2023,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2024,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2025,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2025,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2026,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2027,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2028,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2028,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2028,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2028,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2028,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2029,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2029,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2030,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2030,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2030,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2031,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2031,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2032,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2033,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2033,2,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2033,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2033,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2033,5,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2033,6,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2033,7,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2033,8,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2033,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2033,10,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2033,11,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2033,12,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2033,13,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
2033,14,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2034,1,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2035,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2036,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2037,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2037,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2037,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2037,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2038,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
2039,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2039,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2040,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2041,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2042,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2043,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2043,2,Viral load abnormal,Virus identification and serology,Microbiology and serology investigations,Inv,N
2043,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2043,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2044,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2045,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
2045,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2045,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2045,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2046,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2047,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2047,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2047,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2047,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2047,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2047,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2048,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2049,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2050,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2050,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
2051,1,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2052,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2052,2,Headache,Headaches NEC,Headaches,Nerv,N
2052,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2053,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2053,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2053,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2054,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2055,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2056,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2057,1,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2058,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2058,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2058,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2059,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2060,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2060,2,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2061,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2062,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2063,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2064,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2065,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2066,1,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2066,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2066,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2066,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2067,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2067,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
